Recently published research from MarketLine, "Pharmaceuticals in Germany", is now available at Fast Market Research

Boston, MA -- (ReleaseWire) -- 07/17/2014 --Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.

- The German pharmaceuticals market had total revenues of $35.6bn in 2013, representing a compound annual rate of change (CARC) of -0.2% between 2009 and 2013.

- Government austerity measures designed to curb health care spending including price reductions on patented drugs and a move to purchase more generic drugs have affected growth for the German pharmaceuticals market.

- The performance of the market is forecast to accelerate, with an anticipated compound annual growth rate (CAGR) of 2.1% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $39.4bn by the end of 2018.

View Full Report Details and Table of Contents

Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany

Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Germany economy

Key Questions Answered

What was the size of the Germany pharmaceuticals market by value in 2013?

What will be the size of the Germany pharmaceuticals market in 2018?

What factors are affecting the strength of competition in the Germany pharmaceuticals market?

How has the market performed over the last five years?

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
- OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2013
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013
- Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
- OTC Pharmaceuticals - North America (NAFTA) Industry Guide
- Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for June 2013 in Pharmaceuticals